Considerations for empiric antimicrobial therapy in sepsis and septic shock in an era of antimicrobial resistance
Date
2020-07-21Journal
Journal of Infectious DiseasesPublisher
Oxford University PressType
Article
Metadata
Show full item recordAbstract
Patients with sepsis present across a spectrum of infection sites and severity of illnesses requiring complex decision making at the bedside as to when prompt antibiotics are indicated and which regimen is warranted. Many hemodynamically stable patients with sepsis and low acuity of illness may benefit from further work up before initiating therapy, whereas patients with septic shock warrant emergent broad-spectrum antibiotics. The precise empiric regimen is determined by assessing patient and epidemiological risk factors, likely source of infection based on presenting signs and symptoms, and severity of illness. Hospitals should implement quality improvement measures to aid in the rapid and accurate diagnosis of septic patients and to ensure antibiotics are given to patients in an expedited fashion after antibiotic order. Copyright 2020 Oxford University Press. All rights reserved.Sponsors
Financial support. This study was funded by the Intramural Research Program of the National Institutes of Health Clinical Center.Identifier to cite or link to this item
http://hdl.handle.net/10713/15364ae974a485f413a2113503eed53cd6c53
10.1093/INFDIS/JIAA221
Scopus Count
Collections
Related articles
- Optimizing antimicrobial therapy in sepsis and septic shock.
- Authors: Kumar A
- Issue date: 2009 Oct
- Sepsis and septic shock: selection of empiric antimicrobial therapy.
- Authors: Cunha BA
- Issue date: 2008 Apr
- Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient.
- Authors: De Waele JJ, Dhaese S
- Issue date: 2019 Feb
- Evaluating vancomycin and piperacillin-tazobactam in ED patients with severe sepsis and septic shock.
- Authors: Le C, Chu F, Dunlay R, Villar J, Fedullo P, Wardi G
- Issue date: 2018 Aug
- Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
- Authors: Vazquez-Guillamet C, Scolari M, Zilberberg MD, Shorr AF, Micek ST, Kollef M
- Issue date: 2014 Nov